- Home
- SYTA vs LTRN Comparison
SYTA vs LTRN Comparison
Compare SYTA & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- LTRN
- Stock Information
- Founded
- SYTA N/A
- LTRN 2013
- Country
- SYTA Canada
- LTRN United States
- Employees
- SYTA N/A
- LTRN N/A
- Industry
- SYTA Telecommunications Equipment
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- LTRN Health Care
- Exchange
- SYTA Nasdaq
- LTRN Nasdaq
- Market Cap
- SYTA 38.2M
- LTRN 36.0M
- IPO Year
- SYTA 2020
- LTRN 2020
- Fundamental
- Price
- SYTA $3.03
- LTRN $4.57
- Analyst Decision
- SYTA
- LTRN Strong Buy
- Analyst Count
- SYTA 0
- LTRN 1
- Target Price
- SYTA N/A
- LTRN $25.00
- AVG Volume (30 Days)
- SYTA 658.1K
- LTRN 162.7K
- Earning Date
- SYTA 08-14-2025
- LTRN 08-13-2025
- Dividend Yield
- SYTA N/A
- LTRN N/A
- EPS Growth
- SYTA N/A
- LTRN N/A
- EPS
- SYTA N/A
- LTRN N/A
- Revenue
- SYTA $11,883,835.00
- LTRN N/A
- Revenue This Year
- SYTA $18.41
- LTRN N/A
- Revenue Next Year
- SYTA N/A
- LTRN N/A
- P/E Ratio
- SYTA N/A
- LTRN N/A
- Revenue Growth
- SYTA 49.13
- LTRN N/A
- 52 Week Low
- SYTA $0.93
- LTRN $2.55
- 52 Week High
- SYTA $29.20
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- SYTA 43.98
- LTRN 54.05
- Support Level
- SYTA $2.50
- LTRN $4.11
- Resistance Level
- SYTA $3.85
- LTRN $4.75
- Average True Range (ATR)
- SYTA 0.29
- LTRN 0.44
- MACD
- SYTA -0.07
- LTRN -0.07
- Stochastic Oscillator
- SYTA 39.29
- LTRN 32.68
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.